title: Specific effects of estrogen on growth factor and major histocompatibility complex class II antigen expression in rat aortic allograft.
abstract: OBJECTIVE
  Transplant arteriosclerosis is the major determinant for long-term survival of cardiac transplants. Estradiol treatment inhibits transplant arteriosclerosis. The objective of this study is to determine, in the absence of immunosuppression, the temporal effect of estradiol treatment on the expression of insulin-like growth factor, platelet-derived growth factor, basic fibroblast growth factor, and major histocompatibility complex class II antigen in rat aortic allografts.
  
  
  METHODS
  Orthotopic abdominal aortic allograft transplantation was performed in male rats with Brown-Norway rats used as donors and Lewis rats as recipients. The recipients (n = 50) were treated with estradiol 20 micrograms/kg per day or placebo by osmotic minipump for 2 days before the operation and until they were put to death on postoperative days 1, 3, 7, 14, or 21. The allografts were harvested and insulin-like growth factor, platelet-derived growth factor, basic fibroblast growth factor, and major histocompatibility complex class II antigen expression were determined by immunohistochemical staining. Myointimal thickening was measured by morphometric analysis.
  
  
  RESULTS
  In the placebo-treated group, insulin-like growth factor protein progressively increased in all three layers of the allograft, whereas platelet-derived growth factor protein peaked at day 3 and basic fibroblast growth factor protein increased only moderately. Estradiol treatment inhibited the continuous increase in insulin-like growth factor expression, the peak in platelet-derived growth factor expression at day 3, the moderate-basic fibroblast growth factor increase at day 21, and major histocompatibility complex class II antigen expression in all three layers of the allograft at day 21. Intimal thickening of allografts from estradiol-treated recipients was twofold to threefold less than that of the placebo-treated recipients at day 21.
  
  
  CONCLUSIONS
  The development of transplant arteriosclerosis is associated with an early alloimmune response involving sustained increase in insulin-like growth factor expression. Estradiol treatment of the recipient inhibits transplant arteriosclerosis and suppresses insulin-like growth factor and major histocompatibility complex class II antigen expression but not platelet-derived growth factor or basic fibroblast growth factor in all three layers of the allograft during the early posttransplantation alloimmune rejection phase.
authors.affiliation: Department of Surgery, Georgetown University Medical Center, Washington, D.C. 20007, USA.
authors.forename: S
authors.initials: S
authors.lastname: Saito
authors.forename: N
authors.initials: N
authors.lastname: Motomura
authors.forename: H
authors.initials: H
authors.lastname: Lou
authors.forename: P W
authors.initials: PW
authors.lastname: Ramwell
authors.forename: M L
authors.initials: ML
authors.lastname: Foegh
mesh_terms: D000818:Animals; D001012:Aorta, Abdominal / Q000637:transplantation*; D001161:Arteriosclerosis / Q000276:immunology / Q000517:prevention & control*; D004958:Estradiol / Q000494:pharmacology*; D006133:Growth Substances / Q000096:biosynthesis*; D000949:Histocompatibility Antigens Class II / Q000187:drug effects*; D007150:Immunohistochemistry; D008297:Male; D011183:Postoperative Complications / Q000276:immunology / Q000517:prevention & control*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013997:Time Factors
chemical_list: D006133:Growth Substances; D000949:Histocompatibility Antigens Class II; D004958:Estradiol